Tackling FGFR3-driven bladder cancer with a promising synergistic FGFR/HDAC targeted therapy

Zechen Wang(Yale University), Karen S. Anderson(Yale University)
npj Precision Oncology
July 21, 2023
Cited by 15


Related Papers